11 research outputs found
Successful Expansion but Not Complete Restriction of Tropism of Adeno-Associated Virus by In Vivo Biopanning of Random Virus Display Peptide Libraries
Targeting viral vectors to certain tissues in vivo has been a major challenge in gene therapy. Cell type-directed vector capsids can be selected from random peptide libraries displayed on viral capsids in vitro but so far this system could not easily be translated to in vivo applications. Using a novel, PCR-based amplification protocol for peptide libraries displayed on adeno-associated virus (AAV), we selected vectors for optimized transduction of primary tumor cells in vitro. However, these vectors were not suitable for transduction of the same target cells under in vivo conditions. We therefore performed selections of AAV peptide libraries in vivo in living animals after intravenous administration using tumor and lung tissue as prototype targets. Analysis of peptide sequences of AAV clones after several rounds of selection yielded distinct sequence motifs for both tissues. The selected clones indeed conferred gene expression in the target tissue while gene expression was undetectable in animals injected with control vectors. However, all of the vectors selected for tumor transduction also transduced heart tissue and the vectors selected for lung transduction also transduced a number of other tissues, particularly and invariably the heart. This suggests that modification of the heparin binding motif by target-binding peptide insertion is necessary but not sufficient to achieve tissue-specific transgene expression. While the approach presented here does not yield vectors whose expression is confined to one target tissue, it is a useful tool for in vivo tissue transduction when expression in tissues other than the primary target is uncritical
Peptides enriched in lung tissue during <i>in vivo</i> selection for lung-homing AAV after four rounds of selection
a<p>single letter code; shared amino acid patterns are highlighted in red letters</p>b<p>charge pattern of amino acid side chains: +, positively charged; − negatively charged; x, uncharged polar; y, nonpolar.</p
Vector capsids selected from random AAV display peptide libraries for targeted gene transfer in primary breast cancer cells.
<p>A: Primary PymT breast cancer cells were transduced by recombinant AAV-2 luciferase reporter gene vectors displaying the selected capsid peptide inserts RGDLGLS, RGDMSRE, or DGLGRLV, respectively. Capsids with no (wild-type) or random peptide insert (VRRPRFW) were used as controls. Transduction efficiency was determined after 72 hours by luciferase assay. Luciferase activities are shown in relative light units (RLU) per well. Data represent mean values ± standard deviation (SD) from one representative experiment (out of three) in triplicates (*** = p<0.001 compared to wild-type and random insert controls). B: Breast cancer cell-targeted therapeutic suicide gene transfer using selected capsid mutants. Primary PymT cells were transduced using rAAV-SR39 vectors displaying RGDLGLS or a randomly selected control peptide (VRRPRFW). Four days after initiation of ganciclovir (GCV) treatment, cytotoxic effects were evaluated by MTT assay. Values are shown in % cytotoxicity (i.e., % killed cells). Untreated and untransduced cells served as controls. Data represent mean values ± standard error of the mean (SEM) from nine wells in three independent experiments (*** = p<0.001 selected clone and treated cells vs. all controls).</p
Peptides enriched after PCR-based <i>in vitro</i> selection (pathway A) of AAV peptide libraries on primary breast cancer cells
a<p>single letter code; shared amino acid patterns are highlighted in colored letters</p>b<p>charge pattern of amino acid side chains: +, positively charged; − negatively charged; x, uncharged polar; y, nonpolar.</p>c<p>observed frequency relative to overall number of sequenced clones</p
Targeting of AAV capsid mutants selected on murine lung tissue <i>in vivo.</i>
<p>AAV luciferase vectors displaying selected or control capsids (wild-type or random insert VRRPRFW) were injected intravenously into female FVB mice. Tissue was harvested after 8 or 28 d, respectively, and processed as indicated. A: Evaluation of lung homing. Lung tissue was harvested 8 days after vector injection and the amount of AAV genomes was determined by quantitative PCR. Data represent mean values from n = 3 mice per group, analyzed in triplicates ± SD. B: <i>In vivo</i> lung gene transfer by selected AAV after intravenous injection. Lung tissue was harvested 28 days after vector injection, and luciferase activity was determined as relative light units (RLU) per mg protein. Bars indicate the median value, n = 5 mice per group (** = p<0.001 targeted vectors vs. wild-type and random insert control). C: <i>In vivo</i> transduction of various tissues in mice by AAV library mutants selected for lung transduction. Tissues were harvested and luciferase activity was determined as in 5B. The dotted line indicates the threshold beyond which luciferase expression data could be reliably delineated from background signal. Data represent mean values ± SEM, n = 5 mice per group. * p<0.05; ** p<0.01 targeted vectors vs. wild-type AAV-2. # p<0.05; ## p<0.01 targeted vectors vs. random insert control.</p
Pathways used for selection of targeted viral capsids by screening random AAV display peptide libraries.
<p>For all selection pathways, genomic DNA containing <i>cap</i> gene fragments from internalized library viruses was extracted from the target cells or tissue. Library inserts were amplified by nested PCR and cloned back into the AAV library backbone plasmid pMT-202-6. The resulting pre-selected plasmid library was used to produce a secondary AAV library by transfection into 293T cells and subsequent superinfection with Ad5. Pre-selected AAV libraries were re-subjected to selection on the target cells <i>in vitro</i> or the target tissue <i>in vivo</i>. Preceding the amplification step, the library selection was done according to one of the following three pathways: Pathway A, <i>in vitro</i> selection: A random AAV display peptide library was incubated on primary breast cancer dissociation cultures derived from female tumor-bearing PymT mice. Non-internalized AAV library particles were removed by extensive washing followed by trypsin digestion prior to DNA extraction and AAV insert amplification. Pathway B, <i>in vivo</i>/<i>ex vivo</i> selection: A random AAV display peptide library was injected intravenously into female tumor-bearing PymT mice. After 24 hours, primary tumor cells of the injected mouse were prepared as in pathway A and grown <i>ex vivo</i> for 96 hours prior to DNA extraction and AAV insert amplification. Pathway C, <i>in vivo</i> selection: A random AAV display peptide library was injected as in pathway B in tumor-bearing mice (for selection of tumor-homing AAV) or wild-type mice (for selection of lung homing AAV), respectively. After 48 hours, the target tissue (tumor or lung, respectively) was removed and lysed, and DNA was extracted for AAV insert amplification.</p
Kinetics of circulating AAV peptide library particles is similar to wild-type AAV.
<p>A random X<sub>7</sub> peptide library or wild-type AAV-2 viruses were injected intravenously at 1×10<sup>10</sup> vg per mouse. Blood samples were collected after indicated time points and the amount of circulating viral particles in the serum was determined by real-time PCR. Data represent mean values from n = 3 mice per group, analyzed in triplicates ± SD.</p
Gene delivery by AAV capsid mutants selected for breast cancer transduction <i>in vivo.</i>
<p>AAV luciferase vectors displaying selected peptides or controls (wild-type or VRRPRFW) were injected intravenously into female PymT tumor-bearing mice. After 8 d, representative tissues were harvested and luciferase activities were determined in individual tissues as relative light units (RLU) per mg protein. A: <i>In vivo</i> transduction of tumor tissue in PymT transgenic FVB mice by selected AAV mutants. Bars indicate the median, n = 5 mice per group. * p<0.05 targeted vectors vs. wild-type. # p<0.05 targeted vectors vs. random insert control. B: <i>In vivo</i> transduction of various non-cancerous tissues in PymT transgenic FVB mice by tumor-selected AAV mutants. The dotted line indicates the threshold beyond which luciferase expression data could be reliably delineated from background signal. Data represent mean values ± SEM, n = 5 mice per group. * p<0.05; ** p<0.01 targeted vectors vs. wild-type AAV-2. # p<0.05; ## p<0.01 targeted vectors vs. random insert control.</p
Polarimetry for 3He Ion Beams from Laser–Plasma Interactions
We present a compact polarimeter for 3He ions with special emphasis on the analysis of short-pulsed beams accelerated during laser–plasma interactions. We discuss the specific boundary conditions for the polarimeter, such as the properties of laser-driven ion beams, the selection of the polarization-sensitive reaction in the polarimeter, the representation of the analyzing-power contour map, the choice of the detector material used for particle identification, as well as the production procedure of the required deuterated foil-targets. The assembled polarimeter has been tested using a tandem accelerator delivering unpolarized 3He ion beams, demonstrating good performance in the few-MeV range. The statistical accuracy and the deduced figure-of-merit of the polarimetry are discussed, including the count-rate requirement and the lower limit of accuracy for beam-polarization measurements at a laser-based ion source
A polarized 3He Target for the Exploration of Spin Effects in Laser-induced Plasmas
In order to investigate the polarization degree of laser-accelerated 3He ions from a polarized 3He gas-jet target, several challenges have to be overcome. One of these is the development of an appropriate polarized 3He gas-jet target. Since our experiments are carried out at the PHELIX Petawatt Laser Facility, GSI Darmstadt, the layout of the set-up has to cope with the available space within the PHELIX target chamber. The essential components of such a layout are a magnetic holding field for storing polarized 3He gas inside the vacuum chamber for many hours, the gas-jet source for providing the desired laser target, and finally, a polarimeter for measuring the spin-polarization degree of laser-accelerated 3He2+ ions